Integrating New Data From AIDS 2022

Integrating New Data From AIDS 2022

Tuesday, September 13, 2022 in Miami Beach, FL
Dinner -- Smith and Wollensky - Miami Beach, 6:00 PM ET

Agenda

The timing and agenda for each webinar is as follows:

  • Introduction and Program Overview
  • Key Findings From AIDS 2022
    • Clinical studies of established antiretroviral agents
    • The clinical role(s) of new and investigational ART regimens
    • HIV prevention strategies
  • Question and Answer Session

Faculty

Faculty
Jonathan Appelbaum, MD, FACP, AAHIVS

Laurie L. Dozier Jr, MD, Education Director
Professor of Internal Medicine
Chair,
Department of Clinical Sciences
Florida State University College of Medicine
Tallahassee, Florida

Faculty
Dushyantha T. Jayaweera, MD

Professor of Medicine
Division of Infectious Diseases
Department of Medicine
University of Miami
Professor of Medicine
Attending Physician
Jackson Memorial Hospital
University of Miami Hospital and Clinics
Miami, Florida

Goal Statement
The goal of this activity is to improve learners’ competence in implementing optimal HIV treatment and prevention strategies through the appropriate use of contemporary ARV regimens.

Target Audience
This program is intended for physicians, registered nurses, pharmacists, and other healthcare professionals who provide care for patients with HIV infection.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Integrate best practices in the evidence-based management of ART across the spectrum of ART experience
  • Incorporate the latest data and expert insights on emerging innovative ARV treatment or prevention paradigms into the individualized care of persons with or at risk of HIV infection
  • Appropriately counsel patients regarding the anticipated clinical role of new and investigational ART regimens

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physician Continuing Medical Education

Designation of Credit

CCO designates this live activity for a maximum of 2.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 2.5 contact hours.

Continuing Pharmacy Education

CCO designates this continuing education activity for 2.5 contact hours (0.25 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number - JA4008176-0000-22-174-L02-P

Type of Activity: Application

Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

Disclosure of Conflicts of Interest 
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.